ArticlePakistan journal of medical sciences2025
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From FEVJournal of asthma and allergy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & Objective: Bronchial asthma is a chronic inflammatory disease with reversible airflow obstruction. Smaller airways are primary and most common site of inflammation in bronchial asthma. Methodology: The study included patients who visited the SGRH pulmonary clinic between March to December, 2022. Patients suspected of asthma as per GINA criteria underwent spirometry with bronchodilator reversibility testing, followed by a one-month therapeutic trial. Only those with symptomatic improvement were classified as Clinically confirmed asthma cases and selected for final analysis. A total of 304 non-asthmatic individuals were included as a control group for comparison. Results: A total of 599 individuals, including 295 probable asthmatics, were included in the study. The mean age of participants was 43.2±17.8 years Clinically confirmed asthmatic patients exhibited significantly higher reversibility across all three parameters- Conclusion: Incorporating
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.